Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1962 1
1965 1
1966 1
1967 1
1968 1
1974 1
1977 1
1980 1
1981 1
1983 1
1988 3
1989 2
1990 4
1991 3
1992 8
1993 7
1994 6
1995 3
1996 8
1997 7
1998 3
1999 9
2000 10
2001 9
2002 8
2003 8
2004 16
2005 12
2006 17
2007 30
2008 27
2009 25
2010 28
2011 25
2012 28
2013 31
2014 35
2015 37
2016 35
2017 34
2018 42
2019 44
2020 11
Text availability
Article attribute
Article type
Publication date

Search Results

511 results
Results by year

Citations

511 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
A Screening Test for HLA-B(∗)15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events.
Fang H, et al. Front Pharmacol 2019. Among authors: Riley BJ. PMID 30971914 Free PMC article.
FDA-approved labeling recommends HLA-B(∗)15:02 screening before CBZ therapy in patients of Asian ancestry. In this study, we aimed to (a) identify a direct method for screening HLA-B(∗)15:02, and (b) evaluate prevalence in a large cohort of United States patients. ...Results: 28,897 United States individuals showed 100% concordance between HLA-B(∗)15:02 and the minor allele of rs144012689 (100% sensitivity/99.97% specificity). ...
FDA-approved labeling recommends HLA-B(∗)15:02 screening before CBZ therapy in patients of Asian ancestry. In this study, we aimed to …
511 results
Jump to page
Feedback